We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+35.97%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$392M
AUM Growth
+$211M
Cap. Flow
+$89.7M
Cap. Flow %
22.86%
Top 10 Hldgs %
58.69%
Holding
189
New
48
Increased
30
Reduced
62
Closed
47

Top Sells

Rank Stock Value
1
SKT icon
Tanger
SKT
+$3.39M
2
CPRI icon
Capri Holdings
CPRI
+$3.29M
3
PLCE icon
Children's Place
PLCE
+$3.19M
4
DHIL
Diamond Hill
DHIL
+$2.37M
5
WW
WW International
WW
+$1.88M

Sector Composition

Rank Sector Weight
1 Industrials 6.83%
2 Consumer Discretionary 6.06%
3 Technology 5.36%
4 Financials 5.07%
5 Materials 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOP icon
26
Koppers
KOP
$969M
$2.68M 0.68%
+86,138
New +$2.24M
RGA icon
27
Reinsurance Group of America
RGA
$16.1B
$2.61M 0.67%
+22,538
New +$2.52M
ADEA icon
28
Adeia
ADEA
$3.11B
$2.59M 0.66%
468,376
+179,920
+62% +$780K
DISCK
29
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2.47M 0.63%
94,131
-49,563
-34% -$1.09M
BDC icon
30
Belden
BDC
$5.19B
$2.45M 0.63%
58,528
-13,030
-18% -$481K
ZD icon
31
Ziff Davis
ZD
$1.98B
$2.44M 0.62%
28,697
-5,651
-16% -$409K
CMRE icon
32
Costamare
CMRE
$1.77B
$2.4M 0.61%
290,066
-11,692
-4% -$81.5K
DHIL
33
DELISTED
Diamond Hill
DHIL
$2.39M 0.61%
15,986
-16,255
-50% -$2.37M
TECK icon
34
Teck Resources
TECK
$32.6B
$2.31M 0.59%
127,186
-39,130
-24% -$603K
CBT icon
35
Cabot Corp
CBT
$4.52B
$2.23M 0.57%
49,654
+21,134
+74% +$877K
RYZ
36
Ryerson Holding Corp
RYZ
$1.46B
$2.11M 0.54%
154,789
-14,823
-9% -$145K
VTRS icon
37
Viatris
VTRS
$18.9B
$2.07M 0.53%
110,657
+15,538
+16% +$253K
GCO icon
38
Genesco
GCO
$422M
$2.06M 0.53%
68,488
+126
+0.2% +$3.22K
WFC icon
39
Wells Fargo
WFC
$264B
$2.04M 0.52%
67,437
-1,786
-3% -$46.2K
INTC icon
40
Intel
INTC
$513B
$1.91M 0.49%
+38,381
New +$1.87M
RMR icon
41
The RMR Group
RMR
$332M
$1.89M 0.48%
48,865
+26,245
+116% +$863K
UGI icon
42
UGI
UGI
$7.33B
$1.89M 0.48%
53,913
-32,096
-37% -$1.12M
CAL icon
43
Caleres
CAL
$487M
$1.85M 0.47%
118,084
-58,272
-33% -$652K
MATW icon
44
Matthews International
MATW
$739M
$1.83M 0.47%
62,278
+60,400
+3,216% +$1.56M
UHS icon
45
Universal Health Services
UHS
$10.5B
$1.83M 0.47%
13,321
-8,534
-39% -$1.06M
CSCO icon
46
Cisco
CSCO
$479B
$1.83M 0.47%
40,822
-3,267
-7% -$134K
TAP icon
47
Molson Coors Class B
TAP
$8.09B
$1.82M 0.46%
40,183
-21,343
-35% -$880K
TAP icon
48
CALL
Molson Coors Class B
TAP
$8.09B
$1.75M 0.45%
38,700
-38,800
-50% -$1.6M
T icon
49
AT&T
T
$163B
$1.73M 0.44%
+79,778
New +$1.72M
GRA
50
DELISTED
W.R. Grace & Co.
GRA
$1.64M 0.42%
29,949
-21,145
-41% -$1.06M

Similar funds

Invenomic Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Invenomic Capital Management held 189 positions worth $392M, up 116% from $182M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Invenomic Capital Management deployed $89.7M of net new capital in Q4 2020, opening 48 new positions and adding to 30 existing holdings. Its largest new stake was China Mobile Limited: 154,826 shares worth $4.42M.

By sector, the portfolio is most concentrated in Industrials at 6.8% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Tanger, an estimated $3.39M trimmed.

  • Invenomic Capital Management's largest Q4 2020 buy was China Mobile Limited: 154,826 shares worth $4.42M.
  • Invenomic Capital Management added most to Kinross Gold in Q4 2020, an estimated $3.92M increase.
  • Invenomic Capital Management's biggest Q4 2020 reduction was Tanger, cutting an estimated $3.39M.
  • Invenomic Capital Management fully exited F5 in Q4 2020, selling an estimated $1.62M.
  • Invenomic Capital Management's ten largest holdings make up 59% of its $392M portfolio in Q4 2020.
  • Invenomic Capital Management opened 48 new positions and closed 47 in Q4 2020.
  • Invenomic Capital Management's portfolio value rose 116% quarter-over-quarter to $392M.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.